[1]
|
Marques, A.R.A., Di Spiezio, A., Thiessen, N., et al. (2019) Enzyme Replacement Therapy with Recombinant Pro-CTSD (Cathepsin D) Corrects Defective Proteolysis and Autophagy in Neuronal Ceroid Lipofuscinosis. Autophagy, 16, 811-825. https://doi.org/10.1080/15548627.2019.1637200
|
[2]
|
GBD 2016 Lifetime Risk of Stroke Collabora-tors; Feigin, V.L., Nguyen, G., et al. (2018) Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. The New England Journal of Medicine, 379, 2429-2437.
https://doi.org/10.1056/NEJMoa1804492
|
[3]
|
Shergalis, A.G., Hu, S., Bankhead, A. and Neamati, N. (2020) Role of the ERO1-PDI Interaction in Oxidative Protein Folding and Disease. Pharmacology & Therapeutics, 210, Article ID: 107525.
https://doi.org/10.1016/j.pharmthera.2020.107525
|
[4]
|
Staub, D., Patel, M.B., Tibrewala, A., et al. (2010) Vasa Vasorum and Plaque Neovascularization on Contrast-Enhanced Carotid Ultrasound Imaging Correlates with Cardiovas-cular Disease and Past Cardiovascular Events. Stroke, 41, 41-47.
https://doi.org/10.1161/STROKEAHA.109.560342
|
[5]
|
Brinjikji, W., Rabinstein, A.A., Lanzino, G., et al. (2015) Ultrasound Characteristics of Symptomatic Carotid Plaques: A Systematic Review and Meta-Analysis. Cerebrovascular Diseases, 40, 165-174. https://doi.org/10.1159/000437339
|
[6]
|
中华医学会外科学分会血管外科学组. 颈动脉狭窄诊治指南[J]. 中国血管外科杂志(电子版), 2017, 9(3): 169-175.
|
[7]
|
(1991) North American Symptomatic Ca-rotid Endarterectomy Trial. Methods, Patient Characteristics, and Progress. Stroke, 22, 711-720. https://doi.org/10.1161/01.STR.22.6.711
|
[8]
|
Cui, Q. and Naikoo, N.A. (2019) Modifiable and Non-Modifiable Risk Factors in Ischemic Stroke: A Meta-Analysis. African Health Sciences, 19, 2121-2129. https://doi.org/10.4314/ahs.v19i2.36
|
[9]
|
Yousufuddin, M., Young, N. (2019) Aging and Ischemic Stroke. Aging (Albany NY), 11, 2542-2544.
https://doi.org/10.18632/aging.101931
|
[10]
|
陈海晓, 陈静芸, 浦剑虹, 等. 无症状性颈动脉狭窄患者发生缺血性卒中风险预测列线图模型构建与验证[J]. 实用心脑肺血管病杂志, 2022, 30(9): 55-59.
|
[11]
|
Yaghi, S. and Elkind, M.S. (2015) Lipids and Cerebrovascular Disease: Research and Practice. Stroke, 46, 3322-3328.
https://doi.org/10.1161/STROKEAHA.115.011164
|
[12]
|
Xu, T., Zhang, J.T., Yang, M., et al. (2014) Dyslipidemia and Outcome in Patients with Acute Ischemic Stroke. Biomedical and Environmental Sciences, 27, 106-110.
|
[13]
|
El-Gohary, T.M., Alshenqiti, A.M., Ibrahim, S.R., et al. (2019) Risk Factors and Types of Recurrent Stroke: A Saudi Hospital Based Study. The Journal of Physical Therapy Science, 31, 743-746. https://doi.org/10.1589/jpts.31.743
|
[14]
|
Yu, W. and Cheng, J.D. (2020) Uric Acid and Cardiovascular Disease: An Update from Molecular Mechanism to Clinical Perspective. Frontiers in Pharmacology, 11, Article ID: 582680. https://doi.org/10.3389/fphar.2020.582680
|
[15]
|
Fekadu, G., Chelkeba, L. and Kebede, A. (2019) Retraction Note: Risk Factors, Clinical Presentations and Predictors of Stroke among Adult Patients Admitted to Stroke Unit of Jimma University Medical Center, South West Ethiopia: Prospective Observational Study. BMC Neurology, 19, 327. https://doi.org/10.1186/s12883-019-1564-3
|
[16]
|
张鸥, 刘洋, 蒙航娟, 等. 血浆同型半胱氨酸水平与脑卒中关系研究进展[J]. 中国公共卫生, 2021, 37(12): 1840-1844.
|
[17]
|
Dufouil, C., Beiser, A., McLure, L.A., et al. (2017) Revised Framingham Stroke Risk Profile to Reflect Temporal Trends. Circulation, 135, 1145-1159. https://doi.org/10.1161/CIRCULATIONAHA.115.021275
|
[18]
|
Kim, Y.D., Jung, Y.H. and Saposnik, G. (2016) Traditional Risk Factors for Stroke in East Asia. Journal of Stroke, 18, 273-285. https://doi.org/10.5853/jos.2016.00885
|
[19]
|
Margetic, S. (2012) Inflammation and Haemostasis. Biochemia Medica (Zagreb), 22, 49-62.
https://doi.org/10.11613/BM.2012.006
|
[20]
|
Hartman, J. and Frishman, W.H. (2014) Inflammation and Athero-sclerosis: A Review of the Role of Interleukin-6 in the Development of Atherosclerosis and the Potential for Targeted Drug Therapy. Cardiology in Review, 22, 147-151.
https://doi.org/10.1097/CRD.0000000000000021
|
[21]
|
Raggi, P., Genest, J., Giles, J.T., et al. (2018) Role of In-flammation in the Pathogenesis of Atherosclerosis and Therapeutic Interventions. Atherosclerosis, 276, 98-108. https://doi.org/10.1016/j.atherosclerosis.2018.07.014
|